Phase II Trials of Erlotinib or Gefitinib in Patients with Recurrent Meningioma

There are no established treatments for recurrent meningioma when surgical and radiation options are exhausted. The epidermal growth factor receptor (EGFR) is often over-expressed in meningiomas and may promote tumor growth. In open label, single arm phase II studies of the EGFR inhibitors gefitinib...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Norden, Andrew D., Raizer, Jeffrey J., Abrey, Lauren E., Lamborn, Kathleen R., Lassman, Andrew B., Chang, Susan M., Yung, W.K. Alfred, Gilbert, Mark R., Fine, Howard A., Mehta, Minesh, DeAngelis, Lisa M., Cloughesy, Timothy F., Robins, H. Ian, Aldape, Kenneth, Dancey, Janet, Prados, Michael D., Lieberman, Frank, Wen, Patrick Y.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3786190/
https://ncbi.nlm.nih.gov/pubmed/19562255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-9948-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars